Christian Butter
Distinguished in Heart Failure

Christian Butter

Herzzentrum Brandenburg In Bernau & Medizinische Hochschule Brandenburt, Ladeburger Str. 17, 
Berlin, BE, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Heart Failure
Herzzentrum Brandenburg In Bernau & Medizinische Hochschule Brandenburt, Ladeburger Str. 17, 
Berlin, BE, DE 
OverviewLocationsClinical Research

Overview

Christian Butter practices in Berlin, Germany. Mr. Butter is rated as a Distinguished expert by MediFind in the treatment of Heart Failure. His top areas of expertise are Mitral Valve Regurgitation, Heart Failure, Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

His clinical research consists of co-authoring 232 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 79 articles and participated in 3 clinical trials in the study of Heart Failure.

Gender
Male

Locations

Herzzentrum Brandenburg In Bernau & Medizinische Hochschule Brandenburt, Ladeburger Str. 17, Berlin, BE 16321, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Transcatheter Repair of Mitral Regurgitation With Edwards PASCAL Transcatheter Valve Repair System: A European Prospective, Multicenter Post Market Clinical Follow-Up (PMCF)
Transcatheter Repair of Mitral Regurgitation With Edwards PASCAL Transcatheter Valve Repair System: A European Prospective, Multicenter Post Market Clinical Follow-Up (PMCF)
Enrollment Status: Recruiting
Publish Date: June 26, 2025
Intervention Type: Device
Tiara™ Transcatheter Mitral Valve Replacement Study (TIARA-II)
Tiara™ Transcatheter Mitral Valve Replacement Study (TIARA-II)
Enrollment Status: Completed
Publish Date: September 29, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Post-Market Study Assessment of the Safety and Performance of the MitraClip G4 System
A Post-Market Study Assessment of the Safety and Performance of the MitraClip G4 System
Enrollment Status: Active_not_recruiting
Publish Date: July 11, 2025
Intervention Type: Device
Secondary Prevention of Cardiovascular Disease in the Elderly Trial
Secondary Prevention of Cardiovascular Disease in the Elderly Trial
Enrollment Status: Completed
Publish Date: May 23, 2025
Intervention Type: Drug
Study Drugs: Cardiovascular Polypill, Treatment Prevention for Secondary CV
Study Phase: Phase 3
Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation
Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation
Enrollment Status: Completed
Publish Date: January 16, 2025
Intervention Type: Device
Study Phase: Not Applicable
Randomized, Multi-Center, Event-Driven Trial of TAVI Versus SAVR in Patients With Symptomatic Severe Aortic Valve Stenosis and Intermediate Risk of Mortality, as Assessed by STS-Score - DEDICATE
Randomized, Multi-Center, Event-Driven Trial of TAVI Versus SAVR in Patients With Symptomatic Severe Aortic Valve Stenosis and Intermediate Risk of Mortality, as Assessed by STS-Score - DEDICATE
Enrollment Status: Active_not_recruiting
Publish Date: April 26, 2024
Intervention Type: Device, Procedure
Study Phase: Not Applicable
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Enrollment Status: Completed
Publish Date: October 30, 2023
Intervention Type: Device
Study Phase: Not Applicable
BAROSTIM THERAPY ™ in Heart Failure With Preserved Ejection Fraction: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System
BAROSTIM THERAPY ™ in Heart Failure With Preserved Ejection Fraction: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System
Enrollment Status: Unknown
Publish Date: April 20, 2023
Intervention Type: Device
BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System
BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System
Enrollment Status: Unknown
Publish Date: April 20, 2023
Intervention Type: Device
German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-eluting Bioresorbable Vascular Scaffold System in Patients With Coronary Artery Stenosis
German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-eluting Bioresorbable Vascular Scaffold System in Patients With Coronary Artery Stenosis
Enrollment Status: Completed
Publish Date: April 01, 2022
Intervention Type: Device
A Study of Percutaneous Repair of Functional Mitral Regurgitation Using the Ancora Heart, Inc. AccuCinch® Ventricular Repair System - The CINCH-2 Study
A Study of Percutaneous Repair of Functional Mitral Regurgitation Using the Ancora Heart, Inc. AccuCinch® Ventricular Repair System - The CINCH-2 Study
Enrollment Status: Completed
Publish Date: July 29, 2021
Intervention Type: Device
Study Phase: Not Applicable
Telemedical Interventional Management in Heart Failure II
Telemedical Interventional Management in Heart Failure II
Enrollment Status: Completed
Publish Date: August 03, 2018
Intervention Type: Other, Device
Study Phase: Phase 3
View 11 Less Clinical Trials

232 Total Publications

Transcatheter mitral repair in patients with symptomatic moderate functional mitral regurgitation: 1-year outcomes from the MiCLASP study.
Transcatheter mitral repair in patients with symptomatic moderate functional mitral regurgitation: 1-year outcomes from the MiCLASP study.
Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: August 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Butter's expertise for a condition
ConditionClose
View All 35 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile